United States Electrophysiology Devices Market Outlook to 2025
Orbisresearch.com published “Electrophysiology Devices Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, April 24, 2018 ) GlobalData’s new report, United States Electrophysiology Devices Market Outlook to 2025, provides key market data on the United States Electrophysiology Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Request a Sample PDF of this Report@ http://orbisresearch.com/contacts/request-sample/2121794
Scope:
- Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Electrophysiology Devices market.
- Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
- Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.
Reasons to buy:
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Have any query? Feel free to ask us@ http://orbisresearch.com/contacts/enquiry-before-buying/2121794
Companies Mentioned:
Biosense Webster Inc
Abbott Laboratories
Medtronic Plc
Boston Scientific Corp
Micropace EP Inc.
Fischer Imaging Corp
Some Points from TOC:
1 Table of Contents 2
2 Introduction 6
3 Electrophysiology Devices Market, United States 9
4 Overview of Key Companies in United States, Electrophysiology Devices Market 32
5 Electrophysiology Devices Market Pipeline Products 34
6 Financial Deals Landscape 35
7 Recent Developments 53
7.1 Corporate Communications 53
7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 53
7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 53
7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 53
7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 54
7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 54
7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission 55
7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors 55
7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 56
7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer 56
7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 57
7.1.11 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 57
7.1.12 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 58
7.1.13 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 58
7.1.14 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 58
7.1.15 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 59
7.1.16 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 60
7.1.17 Jun 07, 2017: Harvard Bioscience Elects James Green as Chairman of Board of Directors 60
7.1.18 May 31, 2017: BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe 61
7.1.19 May 26, 2017: Merit Medical Announces Appointment of New Director 61
7.2 Financial Announcements 62
7.2.1 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 62
7.2.2 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 63
7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 64
7.2.4 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 65
7.2.5 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 66
7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 67
7.2.7 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 68
7.2.8 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 69
7.2.9 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 69
7.2.10 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 69
7.2.11 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 70
7.2.12 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 71
7.2.13 Oct 26, 2017: Harvard Bioscience Reports Third Quarter 2017 Financial Results 72
7.2.14 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 73
7.2.15 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 74
7.2.16 Oct 25, 2017: Bard Announces Third Quarter Results 75
7.2.17 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 76
7.2.18 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference 77
7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 78
7.2.20 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine 79
7.2.21 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81
7.2.22 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 82
Continue…
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Browse full report with TOC@ http://orbisresearch.com/reports/index/united-states-electrophysiology-devices-market-outlook-to-2025
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Request a Sample PDF of this Report@ http://orbisresearch.com/contacts/request-sample/2121794
Scope:
- Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Electrophysiology Devices market.
- Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
- Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.
Reasons to buy:
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Have any query? Feel free to ask us@ http://orbisresearch.com/contacts/enquiry-before-buying/2121794
Companies Mentioned:
Biosense Webster Inc
Abbott Laboratories
Medtronic Plc
Boston Scientific Corp
Micropace EP Inc.
Fischer Imaging Corp
Some Points from TOC:
1 Table of Contents 2
2 Introduction 6
3 Electrophysiology Devices Market, United States 9
4 Overview of Key Companies in United States, Electrophysiology Devices Market 32
5 Electrophysiology Devices Market Pipeline Products 34
6 Financial Deals Landscape 35
7 Recent Developments 53
7.1 Corporate Communications 53
7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 53
7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 53
7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 53
7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 54
7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 54
7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission 55
7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors 55
7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 56
7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer 56
7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 57
7.1.11 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 57
7.1.12 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 58
7.1.13 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 58
7.1.14 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 58
7.1.15 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 59
7.1.16 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 60
7.1.17 Jun 07, 2017: Harvard Bioscience Elects James Green as Chairman of Board of Directors 60
7.1.18 May 31, 2017: BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe 61
7.1.19 May 26, 2017: Merit Medical Announces Appointment of New Director 61
7.2 Financial Announcements 62
7.2.1 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 62
7.2.2 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 63
7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 64
7.2.4 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 65
7.2.5 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 66
7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 67
7.2.7 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 68
7.2.8 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 69
7.2.9 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 69
7.2.10 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 69
7.2.11 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 70
7.2.12 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 71
7.2.13 Oct 26, 2017: Harvard Bioscience Reports Third Quarter 2017 Financial Results 72
7.2.14 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 73
7.2.15 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 74
7.2.16 Oct 25, 2017: Bard Announces Third Quarter Results 75
7.2.17 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 76
7.2.18 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference 77
7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 78
7.2.20 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine 79
7.2.21 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81
7.2.22 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 82
Continue…
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Browse full report with TOC@ http://orbisresearch.com/reports/index/united-states-electrophysiology-devices-market-outlook-to-2025
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results